识别与神经病痛相关的m1A/m6A/m5C/m7G相关基因和群

相关实验视频

Updated: Feb 17, 2026

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Cell Subtype-specific Analysis of Neuronal Membrane Proteasome in Somatosensory Neurons

Published on: October 10, 2025

Liangyuan Tan^1,2, Xiaofeng Gan³, Dongming Lu^1,2

¹Department of Rehabilitation Medicine, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, China.

Frontiers in neurology

|February 16, 2026

概括

像Fto和Mettl3这样的RNA甲基化基因与神经病痛 (NP) 有关. 这项研究确定了参与NP进展的关键基因和途径,提供了潜在的治疗点.

科学领域:

表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
分子生物学分子生物学
神经科学是一个神经科学.

背景情况:

RNA甲基化修饰 (m1A,m6A,m5C,m7G) 越来越多地与神经系统疾病有关.
神经病痛 (NP) 是一种具有复杂潜在机制的衰弱性疾病.
了解RNA甲基化在NP中的作用对于开发新疗法至关重要.

研究的目的:

在神经病痛 (NP) 的背景下调查关键的RNA甲基化相关基因 (m1A/m6A/m5C/m7G).
根据RNA甲基化模式识别NP的不同分子亚型.
探索与NP中这些甲基化相关基因相关的功能途径.

主要方法:

从公共数据库下载并分析了NP相关的基因表达数据.
在NP和对照样本之间选差异表达的RNA甲基化相关基因.
利用加权基因共同表达网络分析,蛋白质-蛋白质相互作用分析和功能丰富分析.
通过脊髓神经绑定诱导的NP在老鼠模型中的验证关键发现.

主要成果:

鉴定了六种差异表达的RNA甲基化相关基因:Fto,Mettl3,Nsun2,Ythdf3,Wdr4和Eif4e.
根据RNA甲基化基因表达发现了两个不同的NP集群.
发现集群之间的DEG参与了MAPK和FoxO信号通路.
在老鼠NP模型中观察到Fto,Mettl3,Nsun2和Ythdf3的差异表达.

结论:

像Fto,Mettl3,Nsun2和Ythdf3这样的基因可能参与神经病痛的进展.
在NP中确定了两个不同的RNA甲基化相关的基因表达集群.
MAPK和FoxO信号通路可能在NP的发病过程中发挥重要作用.

关键词:

通过RNA甲基化.集群集群是一个集群集群.不同表达基因的基因.神经病变性疼痛是一种神经性疼痛.路径丰富方式

更多相关视频

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Author Spotlight: A Procedure for Mouse Dorsal Root Ganglion Cryosectioning

Author Spotlight: A Procedure for Mouse Dorsal Root Ganglion Cryosectioning

Published on: June 9, 2023

相关概念视频

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

Cholinergic Receptors: Muscarinic

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....

Nociception

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.